Vijay Kumar, the acting head of the FDA office that oversees new gene therapies, is stepping down from his role after a year in the job. As Kumar’s tenure atop the Office of Therapeutic Products (OTP) ...

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.

Former Finance Secretary and ex-Chief Election Commissioner Rajiv Kumar named part-time chairman Appointment subject to Reserve Bank of India approval Kumar to join board as independent director from ...

New Delhi [India], June 27(ANI): After the names of six security personnel who lost their lives during Operation Sindoor were etched at the National War Memorial, Congress leader Manish Tewari on ...